ProCE Banner Activity

Telemedicine in HCV Care: A Useful Supplement Worth Keeping

Clinical Thought
The COVID-19 pandemic has provided the impetus for nimble and creative strategies that meet patients where they are. In the United States, telemedicine visits are one such strategy—and we should carry them forward in the delivery of care.

Released: September 29, 2021

Expiration: September 28, 2022

Share

Faculty

Stacey B. Trooskin

Stacey B. Trooskin, MD, PhD, MPH

Executive Medical Officer
Mazzoni Center
Faculty, University of Pennsylvania
Perelman School of Medicine
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Educational grants provided by:

AbbVie

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Stacey B. Trooskin, MD, PhD, MPH

Executive Medical Officer
Mazzoni Center
Faculty, University of Pennsylvania
Perelman School of Medicine
Philadelphia, Pennsylvania

Stacey Trooskin, MD, PhD, MPH, has disclosed that she has received funds for research support and consulting fees from Gilead Sciences.